Professor, Neurology, Mayo Clinic
Location: United States
The laboratory of Eugenia Trushina, Ph.D., is focused on mitochondrial dysfunction caused by environmental toxins, chemotherapy drugs, and genetic factors in multiple neurodegenerative disorders, including Huntington's disease and Alzheimer's disease, aging, and chemotherapy-induced peripheral neuropathy.
Her research interests involve the identification of the molecular mechanisms involved in the inhibition of mitochondrial dynamics and function in neurons. Her current projects involve the development of a panel of the specific biomarkers associated with early mechanisms of mitochondrial dysfunction involved in neurodegeneration that could be useful for early diagnosis and monitoring/predicting the progression of multiple diseases, including Alzheimer's disease. She is also testing novel mitochondria-targeted therapeutic approaches that could potentially reverse neurodegeneration and aging.
Dr. Trushina's research has been funded by the Mayo Clinic Alzheimer's Disease Research Center, the American Health Assistance Foundation, the Alzheimer Drug Discovery Foundation, and the National Institutes of Health.
Focus areas
Significance to patient care
Dr. Trushina's research will help to develop novel methods for diagnosis and treatment of neurodegenerative diseases to delay the onset of symptoms and improve quality of life for patients with Alzheimer's disease, Huntington's disease, Parkinson's disease and other neurodegenerative disorders.
No Grants Mentioned !!